期刊文献+

rs10795668单核苷酸多态性与中国北方汉族结直肠癌易感性的关系 被引量:1

Relationship of the polymorphism of rs10795668 single nucleotide and the susceptibility of colorectal cancer in north China Han population
下载PDF
导出
摘要 目的探讨rs10795668单核苷酸多态性与北方汉族人群结直肠癌遗传易感性的关系。方法采用聚合酶链反应-限制性片断长度多态性方法,检测结直肠癌组182例(结肠癌113例,直肠癌69例)和对照组192例的rs10795668单核苷酸多态性基因型。采用非条件logistic回归分析进行基因-疾病关联分析与基因-性别交互作用分析。结果rs10795668多态性位点在结直肠癌患者中的基因型分布与在正常健康对照人群中的基因型分布差异无统计学意义,但基因型与性别在结肠癌中存在交互作用,AA+AG基因型增加女性结肠癌的发生危险(OR=3.05,95%CI 1.47~6.35;P=0.00078)。结论 rs10795668单核苷酸多态性的AA+AG基因型与中国北方汉族女性结肠癌遗传易感性有关,与直肠癌无关。 Objective To evaluate the relationship between the rs10795668 single nucleotide polymorphism (SNP) and the colorectal cancer (CRC) in north China Han population. Methods The genotype of rs10795668 SNP was detected by PCK- RFLP analysis in 113 colon cancer patients, 69 rectal cancer patients, and 192 age and sex matched controls. Unconditional logistic regression were used to comparatively analyze the genotype between patients and the controls adjusted by age and sex. Results No significant difference of rs 10795668 SNP was detected between colorectal cancer patients and normal controls, but it was found that an existence of interaction of gene and sex in colorectal cancer, and women with AA+AG genotype may have lower risk of colon cancer (OR 3.05, 95% CI 1.47-6.35; P=0.00078). Conclusion The AA+AG genotype of rs10795668 SNP is associated with the genetic susceptibility of colon cancer, but not of rectal cancer, in north China Han women.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2015年第10期821-825,共5页 Medical Journal of Chinese People's Liberation Army
基金 解放军306医院院级课题(13QN01 13ZD11)~~
关键词 单核苷酸多态性 结直肠肿瘤 遗传易感性 colorectal cancer genetic susceptibility single nucleotide polymorphism
  • 相关文献

参考文献5

二级参考文献100

  • 1Lauren J, Gunji Y, Alitalo K. Is angiopoietirt-2 necessary for the initiation of tumor angiogenesis? [ J]. Am J Pathol, 1998,153(5) : 1333.
  • 2Huang H, Bhat A, Woodnutt G, et al. Targeting the AN-GPT-TIE2 pathway in malignancy [ J]. Nat Rev Cancer, 2010,10(8) : 575.
  • 3Saharinen P, Eklund L, Pulkki K, et al. VEGF and an- giopoietin signaling in tumor angiogenesis and metastasis [J]. Trends MolMed, 2011,17(7): 347.
  • 4Mannan A, Hahn-Stromberg V. K-ras mutations are corre- lated to lymph node metastasis and tumor stage, but not to the growth pattern of colon carcinoma[ J]. APMIS, 2012, 120(6) : 459.
  • 5Fagiani E, Lorentz P, Kopfstein L, et al. Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis [ J ]. Cancer Res, 2011,71(17) : 5717.
  • 6Gevertz JL, Torquato S. Modeling the efects of vasculature evolution on early brain tumor growth [ J ]. J Theor Biol, 2006,243(4) : 517.
  • 7Kuboki S, Shimizu H, Mitsuhashi N, et al. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor inva- siveness and prognosis in human hepatocellular carcinoma [J]. J Gastroenterol Hepatol, 2008,23(7 Pt 2):e157.
  • 8Holopainen T, Saharinen P, D'Amico G, et al. Effects of angiopoietin-2 blocking antibody on endothelial cell-cell junctions and lung metastasis [ J ]. J Nat1 Cancer Inst, 2012,104(6) : 461.
  • 9Paez-Ribes M, Allen E, Hudock J, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis [ J]. Cancer Cell, 2009,15(3) : 220.
  • 10Ebos JM, Lee CR, Cruz-Munoz W, et al. Accelerated me- tastasis after short-term treatment with a potent inhibitor of tumor angiogenesis [ J ]. Cancer Cell ,2009, 15 ( 3 ) : 232.

共引文献53

同被引文献23

  • 1Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome [J]. Clin Epidemiol, 2013j 6: 1-13.
  • 2Set)i TL, Brown AJ. Polycystic ovary syndrome: update on diagnosis and treatment[J]. AmJ Med, 2014, 127(10): 912-919.
  • 3Robinson KN, Teran-Garcia M. From infancy to aging: Biological and behavioral modifiers of Fetuin-A[J]. Biochimie, 2016, 124: 141-149.
  • 4Auberger P, Falquerho L, Contreres JO, et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification and anti-mitogenic activity[J]. Cell, 1989, 58(4): 631-640.
  • 5Mathews ST, Chellam N, Srinivas PR, et al. A1pha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor[J]. Mol Cell Endocrinol, 2000, 164(1-2): 87-98.
  • 6Mori K, Emoto M Inaba M. Fetuin-A: a multifunctional protein[J]. Recent Pat Endocr Metab Immune Drug Discov, 2011, 5(2): 124-146.
  • 7Sun Q Cornelis MC, Manson JE, et al. Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S.[J]. Diabetes, 2013, 62(1): 49-55.
  • 8Yin L, Cai WJ Zhu LY, et al. Association of plasma Fetuin-A and clinical characteristics in patients with newonset type 2 diabetes mellitus[J]. IntJ Clin Exp Med, 2015, 8(1): 991-999.
  • 9Mfissig K, Staiger H, Machicao F, et al. AHSG gene variation is not associated with regional body fat distribution--a magnetic resonance study[J]. Exp Clin Endocrinol Diabetes, 2009, 117(8): 432-437.
  • 10Siddiq A, Lepretre F, Hercberg S, et al. A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians[J]. Diabetes, 2005, 54(8): 2477-2481.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部